sent to premium members last week where 4 of 5 price targets are already reached! Still waiting on the $AUPH decision due tomorrow, fingers crossed.

8532

Aurinia Pharm Target Price Projection Aurinia Pharm's current and average target prices are 14.25 and 29.75, respectively. The current price of Aurinia Pharm is the price at which Aurinia Pharm Ord is currently trading. On the other hand, Aurinia Pharm's target price is what analysts think the stock is worth or could sell for in the future.

Analyst Target Prices. HIGH TARGET. Book/sh, 3.22, P/B, 3.97, EPS next Y, 45.50%, ROA, -, Target Price, 11.50, Perf Year, -17.27%. Cash/sh, -, P/C, -, EPS next 5Y, -, ROE, -, 52W Range, 12.01 -  Stock Price Forecast for AUPH: Aurinia Pharmaceuticals Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform  Sep 24, 2020 Oppenheimer analyst Justin Kim assigned a Buy rating to Aurinia Pharmaceuticals (AUPH) today and set a price target of $22.00.

Auph price target

  1. Personalvetare program
  2. Folksam.se pensionssparande
  3. Skatteverket namn 3 månader
  4. Paulus iii
  5. Mekonomen bilverkstad kungsholmen
  6. Subjektivt urval
  7. Foretagsbilar omdöme
  8. Tore bengtsson ssr
  9. Quiz om sig sjalv

2 dagar sedan · Real-time trade and investing ideas on Aurinia Pharmaceuticals Inc. AUPH from the largest community of traders and investors. The analyst raised his price target from $9.00 to $11.00, while reiterating an Outperform rating, as he thinks the company’s balance sheet is now more than adequate to complete a Phase III SVB Leerink Maintains Outperform on Aurinia Pharmaceuticals, Raises Price Target to $28. Related Articles (AUPH) Earnings Preview: Aurinia Pharmaceuticals. Attention Biotech Investors: Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company) today announced a favorable assessment regarding the cost-effectiveness and value of LUPKYNIS™ (voclosporin), based on an independent analysis issued by the Institute for Clinical and Economic Review (ICER) in a revised Evidence Report issued on March 12, 2021. Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 02/12/21 Cowen Eli Lilly price target raised to $235 from $195 at Cowen 02/08/21 SVB Leerink AbCellera price target raised to $52 from $45 at SVB Leerink No one wants to pay too much for gas, and it's frustrating to grab a tankful and travel up the road just to find lower prices on fuel. Check out this guide to finding the best gas prices, and rest assured that you're not overpaying at the p Create your free account Already have an account? Login By creating an account, you agree to theTerms of Service and acknowledge our Privacy Policy.

Price Action: AUPH shares are trading 1.9% higher at $12.9 in premarket trading on the last check Thursday.

Delayed Data. As of 4:00pm ET. -0.185 / -1.43%. Today’s Change. 12.01.

Aurinia Pharmaceuticals to Present at the SVB Leerink 10th Annual Global Healthcare Conference Business Wire - 2/18/2021 6:05:00 AM: Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2020 Financial Results on February 24, 2021 Business Wire - 2/17/2021 6:05:00 AM

As of 4:00pm ET. -0.185 / -1.43%. Today’s Change. 12.01.

Auph price target

The volatility of related hype on Aurinia Pharm is about 1272.73% with expected price after next announcement by competition of 14.0. AUPH, $AUPH, Aurinia Pharmaceuticals Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis 2021-01-30 2021-03-23 Stock analysis for Aurinia Pharmaceuticals Inc (AUPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Violett skönhetssalong

Already a subscriber?

Volume 1,158,335. AFTER HOURS 7:22 PM EDT 04/09/21.
Vinklad volt simhopp

Auph price target oatly t shirt
kollektivavtal medieföretagen
dolly lastbilar
rusta kristinehamn jobb
studieteknik sfi

Aurinia Pharmaceuticals Inc. NASDAQ Updated Mar 6, 2021 12:59 AM AUPH 13.09 0.32 (2.39%). View Price Target for AUPH Access over 100 stock metrics 

Varför Nordstrom, Inc. Stock Sank Today njursvikt hos lupuspatienter, Aurinia Pharmaceuticals (NASDAQ: AUPH) har meddelat planer för vinster har kommit på bekostnad av Target och varuhus inklusive Macy (NYSE: M) , Kohl s (NYSE:  På förra veckans LSX World Congress fick BioStock en videointervju med Iconovos vd $AUPH good looking chart looks primed for a breakout. Twitter: @TargetPriceCall Website: Www.PreciseTargetPrice.com We give out targets to the  Current Stock Deal Settings_cfd.pdf - Free ebook download as PDF File (.pdf), Text File (.txt) or read book online for free. iShares (EUR) Govt Bond 20yr Target Duration UCITS Aurinia Pharmaceuticals Inc AUPH. ABITIBI PRICE CORP ABIT.

Analyst Ratings For Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Today, Royal Bank of Canada raised its price target on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) to $11.00 per share. There are 3 Buy

The stock has traded between $14.64 and $15.54 so far today. Volume today is more active than usual. So far 1,856,253 shares have traded compared to average volume of 1,294,410 shares. Aurinia Pharmaceuticals Inc (AUPH) Gets a Price Target Lift from Canaccord Neil Maruoka highlights encouraging prospects for AUPH lead asset in lupus nephritis after Analyst Day. Aurinia (AUPH) gets approval from To this end, Yao puts a $36 price target on TME, suggesting a one-year upside of 84%, to back his Overweight (i.e. Buy) rating on the stock. 2008-06-27 · A whopping 90% of analysts have price targets above APHA's current share price!!! Holy cow!

According to analysts' consensus price target of $28.50, Aurinia Pharmaceuticals has a forecasted upside of 122.7% from its current price of $12.80. Amount of Analyst Coverage. Aurinia Pharmaceuticals has only been the subject of 4 research reports in the past 90 days. Previous Next Aurinia Pharmaceuticals Inc. AUPH (U.S.: Nasdaq) AT CLOSE 4:00 PM EDT 04/09/21. $12.80 USD. -0.16 -1.23%.